Kalaris Therapeutics, Inc. (KLRS) — Cash Flow Reinvestment Rate
Kalaris Therapeutics, Inc. (KLRS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2018, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.94 Million. Explore Kalaris Therapeutics, Inc. cash flow conversion to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kalaris Therapeutics, Inc. Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Kalaris Therapeutics, Inc. across 1 annual periods. Explore Kalaris Therapeutics, Inc. long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Kalaris Therapeutics, Inc. (2018–2018)
Year-by-year capital reinvestment analysis for Kalaris Therapeutics, Inc.. For live market cap and broader valuation context, see Kalaris Therapeutics, Inc. market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.00x | $0.00 | $1.94 Million | $0.00 | — |